A new software called EaSeq enables biomedical researchers to study and test hypotheses using their own data in a matter of hours. This analytical tool improves the analysis of ChIP sequencing data, which holds potential for clinical applications.
A new antibody treatment has shown promise in blocking the process of bone degradation caused by osteosarcoma, a rare type of bone cancer. The treatment reduced bone degradation by up to 80% in a cancer mouse model, offering hope for reducing amputations among young patients.
A University of Copenhagen study reveals that an immune gene, Interferon-beta, may prevent Parkinson's disease and dementia. IFNβ-gene therapy successfully prevented neuronal death in experimental models.
A new study by the University of Copenhagen and Cancer Research UK shows that targeting fibroblasts can block cancer cell movement, trapping them in healthy tissue. The research uses a drug that targets PHD2, an inhibitor currently in clinical trials for anaemia.
Researchers have developed a novel software that translates the effects of cancer mutations on protein function, revealing how disease mutations target and damage protein signaling networks within human cells. The discovery has significant implications for personalized precision cancer treatments.